Arrowhead Publishes First Ever Cholesterol-siRNA Mediated Gene Knockdown in Primates and Novel DPC Co-Injection Strategy

Arrowhead Publishes First Ever Cholesterol-siRNA Mediated Gene Knockdown in Primates and Novel DPC Co-Injection Strategy

[at noodls] – PASADENA, Calif. – November 27, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced the publication of data demonstrating that high level target gene … more

View todays social media effects on ARWR

View the latest stocks trending across Twitter. Click to view dashboard

Share this post